See All Slides - tctmd.com

Slides

Presentation TCT 2013

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Presenter: Masato Nakamura

October 29, 2013

Presentation TCT 2013

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

Presenter: Michael Haude

October 29, 2013

Presentation TCT 2013

Complication Following Left Atrial Appendage Occlusion

Presenter: Brian Whisenant

October 29, 2013

Presentation TCT 2013

Update on ADSCs and MPCs for STEMI

Presenter: Henricus Duckers

October 29, 2013

$Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO$

Presentation TCT 2013

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Presenter: Timothy Henry

October 29, 2013

Presentation TCT 2013

Critical Appraisal of the Frequency, Etiology, and Impact of TAVR Complications

Presenter: Philippe Généreux

October 29, 2013

Presentation TCT 2013

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Presenter: Nils Johnson

October 29, 2013

Presentation

Outcome Data for Devices-Based Repair

Presenter: Ted Feldman

October 29, 2013

Presentation TCT 2013

Return to the Two Cases: Panel Discussion on Treatment Strategies (and Case Conclusions)(2)

Presenter: Anson Cheung

October 29, 2013

Presentation

Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI

Presenter: Stephan Windecker

October 29, 2013

Advertisement

Slides

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

Complication Following Left Atrial Appendage Occlusion

Update on ADSCs and MPCs for STEMI

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Critical Appraisal of the Frequency, Etiology, and Impact of TAVR Complications

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Outcome Data for Devices-Based Repair

Return to the Two Cases: Panel Discussion on Treatment Strategies (and Case Conclusions)(2)

Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content